Wuhan Easy Diagnosis Biomedicine Co.,Ltd. (SHE:002932)

Market Cap	4.10B
Revenue (ttm)	350.06M
Net Income (ttm)	74.52M
Shares Out	219.49M
EPS (ttm)	0.33
PE Ratio	54.96
Forward PE	n/a
Dividend	0.12 (0.63%)
Ex-Dividend Date	n/a

Volume	2,455,654
Average Volume	2,410,694
Open	19.01
Previous Close	19.08
Day's Range	18.56 - 19.15
52-Week Range	15.31 - 21.35
Beta	0.76
RSI	49.38
Earnings Date	Sep 1, 2025

About SHE:002932

Wuhan Easy Diagnosis Biomedicine Co.,Ltd. engages in the research and development, manufacture, and sale of in-vitro diagnostic products China and internationally. Its products portfolio includes molecular diagnostic products, such as PCR system, nucleic acid extraction and purification instrument, and sample release reagent; blood gas analyzer; immuno diagnosis, including chemiluminescence immunoassay, fluorescence immunity, and immunoquantitative analyzer; and automatic coagulation analyzer. The company also provides emergency and critical il...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2008
• Employees: 1,063
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002932

Financial Performance

In 2024, SHE:002932's revenue was 350.06 million, a decrease of -53.30% compared to the previous year's 749.54 million. Earnings were 74.52 million, a decrease of -0.54%.